This site became the new on June 19th. Learn more.
Show more Menu IMPORTANT: Listing of a study on this site does not reflect endorsement by the National Institutes of Health. Talk with a trusted healthcare professional before volunteering for a study. Read more... Menu IMPORTANT: Talk with a trusted healthcare professional before volunteering for a study. Read more... Menu
Give us feedback

Blood Draw Study for Liver Transplant Patients

The recruitment status of this study is unknown. The completion date has passed and the status has not been verified in more than two years.
Verified March 2015 by Baylor Research Institute.
Recruitment status was:  Active, not recruiting
Information provided by (Responsible Party):
Baylor Research Institute Identifier:
First received: May 11, 2011
Last updated: March 13, 2015
Last verified: March 2015
The purpose of this study is to see what a lab test will show and if there is a way to predict which patients will be more likely to have rejection after receiving a liver transplant.

Liver Transplant Recipients

Study Type: Observational
Study Design: Observational Model: Case-Only
Time Perspective: Prospective
Official Title: Immunomonitoring of Transplant Patients

Resource links provided by NLM:

Further study details as provided by Baylor Research Institute:

Primary Outcome Measures:
  • Identify signatures predictive of graft rejection or tolerance. [ Time Frame: 2 years ]
    Analyze the pattern of gene expression in patients undergoing solid organ transplantation

Estimated Enrollment: 200
Study Start Date: October 2002
Estimated Study Completion Date: November 2015
Estimated Primary Completion Date: November 2015 (Final data collection date for primary outcome measure)

Detailed Description:
The purpose of this study is simply to see what the new oligonucleotide microarrays will show when comparing the the different patient groups. The results of this study will be one of the first steps In exploring the potential use of this new test.

Ages Eligible for Study:   17 Years to 65 Years   (Child, Adult)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   Yes
Sampling Method:   Probability Sample
Study Population
Liver Clinic

Inclusion Criteria:

  • Received a liver Transplant

Exclusion Criteria:

  • Received Multiple Organ Transplant
  Contacts and Locations
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the Contacts provided below. For general information, see Learn About Clinical Studies.

Please refer to this study by its identifier: NCT01525797

United States, Texas
Baylor University Medical Center
Dallas, Texas, United States, 752245
Sponsors and Collaborators
Baylor Research Institute
Principal Investigator: Goran Klintmalm, MD Baylor Health Care System
  More Information

Responsible Party: Baylor Research Institute Identifier: NCT01525797     History of Changes
Other Study ID Numbers: 002-197
Study First Received: May 11, 2011
Last Updated: March 13, 2015

Keywords provided by Baylor Research Institute:
Liver Transplant processed this record on August 18, 2017